Stoke Therapeutics STOK - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Stoke Therapeutics Inc (STOK)
Stoke Therapeutics Inc (STOK) Options

Stoke Therapeutics Inc (STOK)

11.52

0.04

(0.35%)

Closed February 03 3:00PM

Delayed by 15 minutes

11.52

-0.005

(-0.04%)

After Hours: 6:00PM

Delayed by 15 minutes

STOK Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	7.60	10.10	11.70	8.85	0.00	0.00 %	0	1	-
5.00	4.70	8.40	6.50	6.55	0.30	4.84 %	293	1,940	2/03/2025
7.50	3.10	5.10	2.50	4.10	0.00	0.00 %	0	532	-
10.00	1.35	5.00	1.25	3.175	0.00	0.00 %	0	894	-
12.50	0.05	1.85	0.60	0.95	0.00	0.00 %	0	1,034	-
15.00	0.20	0.30	0.20	0.25	0.00	0.00 %	0	12	-
17.50	0.05	5.00	0.05	2.525	0.00	0.00 %	0	4	-
20.00	0.35	0.75	0.35	0.55	0.00	0.00 %	0	1	-
22.50	0.21	0.75	0.21	0.48	0.00	0.00 %	0	3	-
25.00	0.35	0.75	0.35	0.55	0.00	0.00 %	0	1	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.05	0.10	0.05	0.075	0.00	0.00 %	0	110	-
7.50	0.05	0.05	0.05	0.05	-0.10	-66.67 %	10	152	2/03/2025
10.00	0.20	0.65	0.30	0.425	0.00	0.00 %	0	131	-
12.50	0.40	5.00	1.70	2.70	0.00	0.00 %	0	65	-
15.00	1.50	6.00	3.75	3.75	0.00	0.00 %	0	0	-
17.50	4.00	8.00	0.00	6.00	0.00	0.00 %	0	0	-
20.00	6.50	10.50	0.00	8.50	0.00	0.00 %	0	0	-
22.50	9.00	13.00	0.00	11.00	0.00	0.00 %	0	0	-
25.00	11.50	15.50	0.00	13.50	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IVVDInvivyd Inc	US$ 1.055 (194.94%)	431.26M
HCWBHCW Biologics Inc	US$ 0.6265 (125.20%)	320.82M
UOKAMDJM Ltd	US$ 0.2293 (76.38%)	326.81M
GHRSGH Research PLC	US$ 17.9991 (69.80%)	9.71M
SOPASociety Pass Inc	US$ 2.43 (59.87%)	106.29M
CYNCYNGN Inc	US$ 0.1169 (-56.70%)	75.52M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1943 (-54.61%)	327.95M
VIRXViracta Therapeutics Inc	US$ 0.0741 (-51.09%)	9.37M
BOWNUBowen Acquisition Corporation	US$ 3.39 (-49.55%)	17.28k
PITAHeramba Electric PLC	US$ 0.503 (-44.11%)	1.37M
IVVDInvivyd Inc	US$ 1.055 (194.94%)	448.53M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0462 (27.98%)	434.24M
NVDANVIDIA Corporation	US$ 116.66 (-2.84%)	371.47M
UOKAMDJM Ltd	US$ 0.2293 (76.38%)	354.09M
HCWBHCW Biologics Inc	US$ 0.6265 (125.20%)	344.42M

PonkenPlonken

PonkenPlonken 2 months ago

I am so STOKED about this company. They were doing this before they all figured out you need RNA science for gene therapy.
See SRPT ARWR deal! another AAV based gene tx seeking RNAI

Monksdream

Monksdream 5 months ago

Zardiw

Zardiw 10 months ago

$STOK Chart from #DDAmanda - #1 Stock Screener :

Scans are preset. Push a Button. Find Winners Early:

Z

TimeFades

TimeFades 10 months ago

Choppy day shoulda just stuck with my morning short

TimeFades

TimeFades 10 months ago

Got bullish again and covered

TimeFades

TimeFades 10 months ago

Invest-in-America

Invest-in-America 10 months ago

STOK: "Stoke Therapeutics (NASDAQ:STOK) stock shot up 70% in post-market trading Monday after the company reported positive results from studies for its drug STK-001 in the treatment of children and adolescents with Dravet syndrome, a genetic form of epilepsy. The biotech company said data from two Phase 1/2a studies and two open label extension, or OLE, studies showed “clinically meaningful effects” that included “substantial and durable reductions in convulsive seizure frequency."
https://seekingalpha.com/news/4083468-stoke-stock-soars-post-market-on-epilepsy-drug-data

Dravet Syndrome is an extremely RARE disease in the USA. And the above news does NOT specify nor suggest that STOK's (potential) treatment for Dravet Syndrome will or might have any applications for treatment of EPILEPSY at all. (Be very CAREFUL about news like the above.)

Stoke Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions